Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Anxiety Associated With Severe COPD
NCT01522092Phase 3Withdrawn
- Sponsor
- Hull University Teaching Hospitals
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Escitalopram oxalate oral solution in anxiety disorder, sponsored by Hull University Teaching Hospitals. Status: withdrawn.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01522092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522092.